Amasya University has unveiled a clinical investigation involving an innovative AI-driven whole-body electrical stimulation medical device designed to address chronic back pain. This new device combines advanced technology with electrical therapy to enhance assessments and potentially improve patient outcomes. The study, detailed on ClinicalTrials.gov, is not yet recruiting participants.
What are the study details?
The clinical trial, titled “Assessing Spinal Pain With an Artificial Intelligence-assisted Whole Body Electrical Stimulation Device,” aims to evaluate the practicality and efficacy of a novel medical device for spinal pain management. Chronic back pain remains a widespread condition, often challenging for healthcare providers to treat effectively.
According to the information listed on ClinicalTrials.gov, the trial is sponsored by Amasya University, a prominent institution recognized for advancements in medical research. Recruitment for the study has not commenced as of the publication date but highlights the increasing focus on AI’s role in healthcare.
What is the intended purpose of the device?
The AI-assisted device in this clinical trial is designed to evaluate and manage chronic back pain using precise whole-body electrical stimulation. By employing artificial intelligence, the device aims to collect comprehensive data, analyze patient conditions, and offer personalized therapy recommendations. This method could maximize treatment precision and improve the safety profile compared to traditional methods.
The integration of AI ensures real-time feedback on treatment efficacy, providing an evidence-based approach to managing spinal pain. This aligns closely with MDR Annex XIV requirements, emphasizing performance, safety, and reliability.
Who is affected by chronic back pain?
Chronic back pain is a prevalent global health issue, impacting individuals of various age groups and demographics. Many patients suffer diminished quality of life due to persistent discomfort and limited mobility. For healthcare providers, finding effective interventions for patients with resistant pain conditions can be particularly difficult.
This clinical study could introduce breakthroughs in treatment options, offering new hope to patients and setting higher performance benchmarks for medical devices addressing back pain.
Frequently Asked Questions
1. Is the study currently recruiting participants?
No, the trial is currently marked as “Not yet recruiting” according to ClinicalTrials.gov.
2. Who is sponsoring this study?
Amasya University is serving as the primary sponsor for this investigation.
3. What condition does the device target?
The AI-powered whole-body electrical stimulation device is designed specifically to address chronic back pain.
4. Where can I find detailed trial information?
Details about the clinical study can be found here.
Conclusion: Implications for stakeholders
AI-powered medical devices continue to advance healthcare by integrating technology into diagnostic and therapeutic approaches. This upcoming study highlights the promise of combining artificial intelligence with electrical stimulation to enhance outcomes for chronic back pain sufferers. Regulatory and clinical teams should monitor advancements of this nature closely, ensuring compliance with global medical device standards.
Disclaimer
This article is intended for informational purposes only and does not constitute legal, regulatory, or medical advice. Professionals should consult official sources for guidance.
Study announcement link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07244237?term=medical+device